Erythropoietin receptor (EPO-R) drugs for Chronic Kidney Disease

5 tracked Erythropoietin receptor (EPO-R) drugs in the Chronic Kidney Disease race. The class explanation lives on the Erythropoietin receptor (EPO-R) page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.

4 Phase 31 Phase 2

Head-to-head evidence: JR-131 vs Loncipoetin alfa (NuPIAO) · JR-131 vs NNG-DEPO · JR-131 vs Pegmolesatide (HS-20039) · JR-131 vs RD01 (PEG-EPO) · Loncipoetin alfa (NuPIAO) vs NNG-DEPO · Loncipoetin alfa (NuPIAO) vs Pegmolesatide (HS-20039)

The roster

← all Erythropoietin receptor (EPO-R) drugs